T1	Intervention 31 88	plasma-derived heat-inactivated hepatitis B vaccine (CLB)
T2	Intervention 199 256	plasma-derived heat-inactivated hepatitis B vaccine (CLB)
T3	Intervention 466 579	three 3-micrograms doses of heat-inactivated hepatitis B surface antigen (HBsAg) at one-month intervals (trial A)
T4	Intervention 813 854	f five different dosages of the vaccine w
